March 06, 2015 12:52 PM ET


Company Overview of Celtaxsys, Inc.

Executive Profile

Michael R. Hanley Ph.D.

Former Chairman of the Board and Chief Executive Officer, Celtaxsys, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships


Dr. Michael R. Hanley, Ph.D., served as the Chief Executive Officer of Celtaxsys, Inc. since December 2, 2010 until September 9, 2013. Dr. Hanley served as Vice President of Discovery Research of Amylin Pharmaceuticals, Inc. since October 2003 and served as its Chief Scientific Officer. From 1997 to 2003, he served as a Senior Consultant for healthcare investors in the venture capital and banking communities and for biotechnology companies such as Cell Therapeutics, ...

Corporate Headquarters

311 Ferst Drive
Atlanta, Georgia 30332

United States

Phone: 404-920-0702
Fax: 404-920-0701

Board Members Memberships

Former Chairman of the Board and Chief Executive Officer


University of California Berkeley
University of California Berkeley
University of California Berkeley

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celtaxsys, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at